CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Chronic lymphocytic leukemia (CLL) is associated with CD8(+) T cell exhaustion and impaired function.
• Antiviral responses, specifically against cytomegalovirus (CMV), appear largely preserved in untreated CLL patients.
• This suggests a potential dichotomy in T-cell functionality within the CLL microenvironment.

Purpose of the Study:

• To investigate the phenotypic and functional characteristics of CMV-specific CD8(+) T cells in CLL patients compared to healthy controls (HCs).
• To determine if CMV-specific CD8(+) T cells are affected by the general T-cell exhaustion observed in CLL.
• To assess the functional integrity of antiviral responses mediated by CMV-specific CD8(+) T cells in CLL.

Main Methods:

• Phenotypic analysis of inhibitory receptor expression (PD-1, CD160, CD244) on total and CMV-specific CD8(+) T cells using flow cytometry.
• Functional assessment of cytokine production upon stimulation and cytotoxic killing of CMV-peptide-loaded target cells.
• Quantitative imaging flow cytometry to evaluate immunologic synapse formation between CMV-specific CD8(+) T cells and antigen-presenting cells.

Main Results:

• CMV-specific CD8(+) T cells (identified by CMV-tetramer staining) in CLL patients exhibited lower expression of exhaustion markers (PD-1, CD160, CD244) compared to total CD8(+) T cells.
• These CMV-specific CD8(+) T cells demonstrated intact cytokine production and cytotoxic activity against CMV-infected targets, similar to HCs.
• The formation of immunologic synapses by CMV-specific CD8(+) T cells was also comparable between CLL patients and HCs.

Conclusions:

• Despite global T-cell dysfunction in CLL, CMV-specific CD8(+) T cells are phenotypically distinct, showing reduced exhaustion.
• These cells retain functional competence in antiviral immunity, including cytokine production, cytotoxicity, and synapse formation.
• These findings suggest greater heterogeneity within the T-cell compartment in CLL than previously understood, with potential implications for immune surveillance and therapy.